< Back to Article
First-line systemic treatment strategies for unresectable hepatocellular carcinoma: A cost-effectiveness analysis
Fig 2
Cost-effectiveness acceptability curves.
QALYs, quality-adjusted life-years.
doi: https://doi.org/10.1371/journal.pone.0279786.g002